| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.47B | 15.54B | 12.19B | 13.20B | 13.92B | 20.38B |
| Gross Profit | 11.93B | 11.56B | 9.48B | 9.93B | 10.68B | 16.64B |
| EBITDA | 6.54B | 7.43B | 4.22B | 5.40B | 4.44B | 5.21B |
| Net Income | 4.04B | 3.63B | 3.06B | 4.27B | 3.19B | 3.48B |
Balance Sheet | ||||||
| Total Assets | 328.45B | 318.25B | 292.96B | 259.60B | 258.35B | 239.11B |
| Cash, Cash Equivalents and Short-Term Investments | 258.88B | 87.14B | 137.12B | 116.55B | 123.60B | 133.46B |
| Total Debt | 77.49B | 136.06B | 66.34B | 68.34B | 69.70B | 77.23B |
| Total Liabilities | 252.37B | 256.42B | 223.74B | 191.71B | 193.57B | 180.51B |
| Stockholders Equity | 75.19B | 60.95B | 68.39B | 67.09B | 64.00B | 57.87B |
Cash Flow | ||||||
| Free Cash Flow | 3.07B | 4.70B | 36.01B | 15.08B | 18.04B | -5.13B |
| Operating Cash Flow | 3.35B | 4.96B | 36.38B | 15.58B | 18.33B | -4.83B |
| Investing Cash Flow | -6.33B | -31.31B | -15.04B | -14.81B | -9.03B | 6.68B |
| Financing Cash Flow | 16.25B | 7.94B | -8.27B | -4.11B | -6.47B | -462.36M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$161.23B | 15.34 | 10.09% | 0.97% | 8.40% | 78.28% | |
69 Neutral | HK$349.10B | 12.78 | 6.85% | 2.75% | 91.20% | 30.16% | |
68 Neutral | HK$222.07B | 19.02 | 10.70% | 2.80% | 2.39% | 46.72% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | HK$478.49B | 12.67 | 11.64% | 2.05% | 48.94% | 36.64% | |
63 Neutral | HK$209.38B | 11.09 | 9.27% | 2.92% | 28.52% | 6.24% | |
61 Neutral | HK$73.68B | 17.71 | 6.25% | 2.66% | 14.46% | 25.89% |